Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders
Key facts
- Who runs it
- Institut de Myologie, France
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 1 Dec 2021
- Ended
- 22 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Lower-limb powered dermoskeleton
- Record updated
- 16 April 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- 18 years and < 70 years of age
- Height between 1.50 m and 1.95 m
- Weight between 45 kg and 110 kg
- Abdominal perimeter < 125 cm
- Written informed consent
- Affiliate or beneficiary of a social security scheme
- Able to comply with all protocol requirements
- Confirmed diagnosis of a pathology belonging to one of the following family*:; Primary disorders of muscles; Muscular dystrophy; Congenital myopathies; Idiopathic inflammatory myopathy; Mitochondrial myopathies; Metabolic disorders; Inborn errors of metabolism
- Glycogen storage disease
- Functional capacities:; Able to stand up from a chair with armrest without other supports at least 3 times and at most 15 times in 30 seconds; Report the ability to walk without the assistance of a person at least 2min; The use of traditional orthoses and walking aids will be accepted excepted knee orthoses and walkers (e.g. canes/crutches, ankle foot orthosis)
Who cannot take part
- Medical history of osteoporotic fracture
- Balance disorder with extra neuromuscular causes
- Severe respiratory insufficiency
- Unable to participate in the study
- Inability to comply with protocol requirements
- Guardianship/trusteeship
- Pregnant or nursing women
- Unstable Cardiomyopathy
- Symptomatic orthostatic hypotension
- Recent trauma (fall, accident, ...)
- Unstable Cardiomyopathy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aims of the current study are as follow:
Read full original descriptionShow less
i) Evaluate the safety, usability, and acute efficiency of a programmable ambulation exoskeleton (KeeogoTM Dermoskeleton System, B-Temia Inc., Quebec, Canada) in patients with neuromuscular disorders, ii) Elaborate recommendations regarding usability criteria for safe and efficient use the device in patients with neuromuscular disorders (e.g. type and severity of patient's functional deficits), iii) generate necessary data to foresee a future study involving a home use of the device and assessment of long-term benefits.
The 2 groups in the trial
- Lower-limb powered dermoskeletonTreatment being tested
Patients and healthy subjects will use a lower-limb powered dermoskeleton to perform different standardised tasks
- No assistance deviceNo study treatment, for comparison
Patients and healthy subjects will perform different standardised tasks without lower-limb powered dermoskeleton
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 16 April 2026